» Articles » PMID: 14602785

Phenotypic Heterogeneity in Body Fat Distribution in Patients with Congenital Generalized Lipodystrophy Caused by Mutations in the AGPAT2 or Seipin Genes

Overview
Specialty Endocrinology
Date 2003 Nov 7
PMID 14602785
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

Congenital generalized lipodystrophy (CGL) is a rare autosomal recessive syndrome characterized by extreme paucity of adipose tissue since birth, acanthosis nigricans, severe insulin resistance, marked hypertriglyceridemia, and early-onset diabetes mellitus. Recently, we reported mutations in the 1-acylglycerol-3-phosphate O-acyltransferase 2 (AGPAT2) gene in CGL pedigrees linked to chromosome 9q34 (CGL1 subtype), and mutations in the Seipin gene were reported in pedigrees linked to chromosome 11q13 (CGL2 subtype). Whether the two subtypes have differences in body fat distribution has not been investigated. We, therefore, compared whole-body adipose tissue distribution by magnetic resonance imaging in 10 CGL patients, of whom seven (six females, one male) had CGL1 and three (two males, one female) had CGL2. Both subtypes had marked lack of metabolically active adipose tissue located at most sc, intermuscular, bone marrow, intraabdominal, and intrathoracic regions. Paucity of mechanical adipose tissue in the palms, soles, orbits, scalp, and periarticular regions was noted in CGL2, whereas it was well preserved in CGL1 patients. We conclude that CGL patients with Seipin mutations have a more severe lack of body fat, which affects both metabolically active and mechanical adipose tissue, compared with patients with mutations in the AGPAT2 gene.

Citing Articles

Function and Regulation of Bone Marrow Adipose Tissue in Health and Disease: State of the Field and Clinical Considerations.

Zhang X, Tian L, Majumdar A, Scheller E Compr Physiol. 2024; 14(3):5521-5579.

PMID: 39109972 PMC: 11725182. DOI: 10.1002/cphy.c230016.


A rapid action plan to improve diagnosis and management of lipodystrophy syndromes.

Fourman L, Lima J, Simha V, Cappa M, Alyaarubi S, Montenegro Jr R Front Endocrinol (Lausanne). 2024; 15:1383318.

PMID: 38952397 PMC: 11215967. DOI: 10.3389/fendo.2024.1383318.


GLP-1 receptor agonist improves metabolic disease in a pre-clinical model of lipodystrophy.

Roumane A, Mcilroy G, Sommer N, Han W, Heisler L, Rochford J Front Endocrinol (Lausanne). 2024; 15:1379228.

PMID: 38745956 PMC: 11091257. DOI: 10.3389/fendo.2024.1379228.


Lipid droplet biogenesis and functions in health and disease.

Zadoorian A, Du X, Yang H Nat Rev Endocrinol. 2023; 19(8):443-459.

PMID: 37221402 PMC: 10204695. DOI: 10.1038/s41574-023-00845-0.


DNA repair-related genes and adipogenesis: Lessons from congenital lipodystrophies.

de Melo Campos J, Oliveira M, Soares L, Medeiros K, Campos L, Lima J Genet Mol Biol. 2022; 45(3 Suppl 1):e20220086.

PMID: 36354755 PMC: 9648094. DOI: 10.1590/1678-4685-GMB-2022-0086.